The ACR honored 19 members for outstanding contributions to the ACR and the field of rheumatology.
Search results for: pediatric
The Who, What & Where of Rheumatology
In the Medical Education Year in Review session at ACR Convergence 2024, David Leverenz, MD, MEd, discussed the current make-up of rheumatology, how competency is measured and how to help rheumatology fellows thrive.
ACR Updates Position Statement on Complementary & Integrative Medicine for Rheumatic Disease
The position refers to relevant ACR clinical guidelines and supports continued research and innovative methods for evaluating these modalities in clinical practice.
ACR Honors Distinguished Fellows: Class of 2024
At ACR Convergence 2024, the ACR honored clinical and research fellows in programs from New York to California and points between.
Tackling the Rheumatology Workforce Shortage
WASHINGTON, D.C.—The workforce shortage in rheumatology is a looming crisis that demands immediate attention. The ACR’s 2015 Workforce Study projected that by 2030, the supply of adult rheumatologists would dwindle by 31%, in contrast to the increase in demand by close to 138%.1 The situation is even worse for pediatric rheumatology and in rural and…
ACR On Air: Occupational Therapy Hones in on Making Daily Activities Easier
Occupational therapist Cheryl Crow, who lives with rheumatoid arthritis, shares the ins and outs of what OT is and how it can help those with rheumatic conditions.
Rheum After 5: Dr. Elizabeth Hazel, Olympian
Dr. Elizabeth Hazel reflects on her experience as a Canadian swimming competitor in the 1992 Summer Olympics.
Lupus & Nightmares
Dr. David D’Cruz’s research attempts to help patients make sense of chronic nightmares, an understudied symptom of lupus.
Can Primary Care Physicians Help Rheumatology’s Workforce Shortages?
In an effort to ameliorate serious rheumatology provider shortages, the ACR Workforce Solutions Committee has developed a new resource for primary care providers who treat patients with rheumatic conditions.
AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM
Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 112
- Next Page »